Literature DB >> 2545926

Cytopathic effects induced by Epstein-Barr virus replication in epithelial nasopharyngeal carcinoma hybrid cells.

H Sato1, T Takimoto, S Tanaka, H Ogura, K Shiraishi, J Tanaka.   

Abstract

NPC-KT cl.S61, a subclone derived from an epithelial-nasopharyngeal carcinoma hybrid cell line (NPC-KT), showed cytopathic changes characteristic of herpesvirus replication, including formation of multinucleated giant cells and inclusion bodies, when Epstein-Barr virus replicative cycle was induced by 5-iodo-2'-deoxyuridine. Acyclovir (an inhibitor of herpesvirus DNA polymerase), Epstein-Barr virus-immune human serum, or 2-deoxyglucose (an inhibitor of the glycosylation) interfered with syncytium formation, indicating that a virus-specified glycoprotein belonging to the late group is responsible for cell fusion induced by Epstein-Barr virus replication in cl.S61 cells.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2545926      PMCID： PMC250938          DOI： 10.1128/JVI.63.8.3555-3559.1989

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  20 in total

1.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

Authors:  M A EPSTEIN; B G ACHONG; Y M BARR
Journal:  Lancet       Date:  1964-03-28       Impact factor: 79.321

2.  Isolation of infectious EB virus from the epithelial tumour cells of nasopharyngeal carcinoma.

Authors:  P A Trumper; M A Epstein; B C Giovanella; S Finerty
Journal:  Int J Cancer       Date:  1977-11-15       Impact factor: 7.396

3.  EB viral genomes in epithelial nasopharyngeal carcinoma cells.

Authors:  H Wolf; H zur Hausen; V Becker
Journal:  Nat New Biol       Date:  1973-08-22

4.  Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis.

Authors:  G Henle; W Henle; V Diehl
Journal:  Proc Natl Acad Sci U S A       Date:  1968-01       Impact factor: 11.205

5.  Persistence of Epstein-Barr virus in the parotid gland.

Authors:  H Wolf; M Haus; E Wilmes
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

6.  Isolation of transforming and early antigen-inducing Epstein-Barr virus from nasopharyngeal carcinoma hybrid cells (NPC-KT).

Authors:  T Takimoto; H Ogura; H Sato; R Umeda; M Hatano
Journal:  J Natl Cancer Inst       Date:  1985-01       Impact factor: 13.506

7.  Epstein-Barr virus replication in oropharyngeal epithelial cells.

Authors:  J W Sixbey; J G Nedrud; N Raab-Traub; R A Hanes; J S Pagano
Journal:  N Engl J Med       Date:  1984-05-10       Impact factor: 91.245

8.  Epstein--Barr virus-induced cell fusion.

Authors:  G J Bayliss; H Wolf
Journal:  Nature       Date:  1980-09-11       Impact factor: 49.962

9.  An Epstein--Barr virus early protein induces cell fusion.

Authors:  G J Bayliss; H Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

10.  Replication of Epstein-Barr virus in human epithelial cells infected in vitro.

Authors:  J W Sixbey; E H Vesterinen; J G Nedrud; N Raab-Traub; L A Walton; J S Pagano
Journal:  Nature       Date:  1983 Dec 1-7       Impact factor: 49.962
View more
  4 in total

1.  Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs.

Authors:  B C Schaefer; J L Strominger; S H Speck
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

2.  Opportunistic DNA Recombination With Epstein-Barr Virus at Sites of Control Region Rearrangements Mediating JC Virus Neurovirulence.

Authors:  Margaret J Wortman; Patric S Lundberg; Ayuna V Dagdanova; Pranav Venkataraman; Dianne C Daniel; Edward M Johnson
Journal:  J Infect Dis       Date:  2015-12-21       Impact factor: 5.226

3.  Epstein-Barr virus BZLF1 transactivator is a negative regulator of Jun.

Authors:  H Sato; H Takeshita; M Furukawa; M Seiki
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

4.  JC virus T-antigen regulates glucose metabolic pathways in brain tumor cells.

Authors:  Evan Noch; Ilker Kudret Sariyer; Jennifer Gordon; Kamel Khalili
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.